Navigation Links
Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model

Mymetics Also Announces Deal for Vaccine Delivery System

NYON, Switzerland, March 29, 2007 /PRNewswire-FirstCall/ -- Mymetics Corporation announced today that the Company's HIV vaccine elicited IgA mucosal antibodies in a non-human primate model. Mucosal IgA antibodies are considered a possible first line of defense against infection by HIV. The data were presented by Sylvain Fleury, Ph.D., Mymetics' Chief Scientific Officer in an oral presentation, "Without Mucosal Adjuvant, Virosomes-gp41 Peptides from the MPR can Elicit Protective Mucosal IgA in Vaccinated Macaques," at the Keystone Symposium, HIV Vaccines: From Basic Research to Clinical Trials. The meeting is being supported by the Bill & Melinda Gates Foundation.

"The results are a striking example of the progress we have seen in applying our vaccine based on the gp41, a well-conserved HIV surface membrane protein," commented Dr. Fleury. "Previously, our team was the first to be able to synthesize a trimeric, soluble and stable formulation of gp41 that could be used in a vaccine. Now, by showing that we can elicit IgA mucosal antibodies in vaginal and rectal tissues, we have taken a major step in being able to prepare materials for a submission to begin studies in human patients. We expect that this submission could take place as early as the third quarter of 2008."

Mymetics also announced that it has signed an exclusive license with Pevion Biotech for the use of Virosomes(R) in the production of its HIV vaccine. Virosomes are a market-approved carrier system for the delivery of pharmaceutically or immunologically active substances, allowing the correct spatial presentation of peptides and proteins and facilitating delivery of Mymetics' HIV vaccine without the use of an adjuvant. Additional details were not disclosed.

Christian Rochet, Mymetics' President and Chief Executive Officer, stated, "We believe that our exclusive agreemen
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Mymetics HIV Vaccine Demonstrates First-Ever Production of Neutralizing IgA Antibodies in Non-Human Primate Model
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
5. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
6. Vaccine Can Prevent Cervical Cancer and Precancerous Lesions
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
9. HepaLifes PBS-1 Cells for Influenza Vaccine Production Prove Superior at International Conference
10. New Flu Vaccine from PepTcell Could Provide Immunity Against All Strains of Influenza Virus
11. Hypertension Vaccine CYT006-AngQb Achieves Strong Blood Pressure Reduction During Important Early Morning Period When Most Adverse Cardiovascular Events Occur

Post Your Comments:
(Date:11/9/2009)...swire/ -- Access MediQuip, LLC, the nation,s first...dical device management solutions to the healthcar...its corporate headquarters to Lake Mary, Florida. ...growth, includes a major expansion of the Primera ...uary 2010 and relocation and expansion of the Hous...
(Date:11/9/2009)...tCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: IST...ompany,s Bepreve(TM) (bepotastine besilate ophthal...e results were presented in poster sessions at the...lergy, Asthma & Immunology (ACAAI) in Miami Be...Treatment of Ocular Itching with Bepotastine Besil...
(Date:11/9/2009)...wswire/ -- Thomson Reuters today announced the n...eading clinical surveillance solution that enables...me and respond immediately to improve clinical qua...s upgrade is available to current CareFocus custom...ontains several powerful enhancements that improve...
Breaking Medicine Technology:Access MediQuip Moves Company Headquarters to Lake Mary, Florida 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 2ISTA Pharmaceuticals Highlights Bepreve(TM) Clinical Data at the 2009 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) 3Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Proteins in gel 8982 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 1PharmaVentures Assists Helsinn in the Successful Sale of Helsinn Chemicals Ireland to the Medinco C F M Group 12767 2PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 1PHT Names VP to Lead Sales of A Claim Payment Solution for Doctors Hospitals 49924 2
...stent may hold clinical edge over Taxus stent at t..., March 31 Early results of the SPIRIT II study,s...Taxus stent in six-month,findings on angiography a...ow, a new analysis shows that after two years, the... may continue to hold a clinical edge over,its pac...
...any,s TAXUS(R) and PROMUS(TM) Stents demonstrate p...mes, NATICK, Mass. and CHICAGO, March 31 Boston,...d positive two-year results,from Abbott,s prospect...ty,SPIRIT II Trial comparing the safety and effica...ting Coronary Stent and Boston Scientific,s,worldw...
Other Medicine Technology:SPIRIT II Explores Long-Term Performance of XIENCE V Stent 2SPIRIT II Explores Long-Term Performance of XIENCE V Stent 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 2Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 3Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms 4
(Date:11/9/2009)... , Fast food chains are o...obesity. A recent poll by Fitness.com.au however f...shoulder the responsibility. , ...ast food chains, and video games were behind Austr...nd Dad are more than just innocent bystanders. A r...
(Date:11/9/2009)... , New study highlights p...health , Rosemont, IL (Vo...ncrease and bone health decreases. Recent research...lcium supplements to help prevent these issues. Ho...ber issue of Sports Health: A Multidisciplinary A...
(Date:11/9/2009)... , LEBANON, Tenn., Nov. 9 Hea...oday announced it will host their inaugural Hospit...3-15, 2010 at the Marriott Renaissance Hotel in Na...pecting more than 100 hospital operating room dire...als and health systems in the country. Some of the...
(Date:11/9/2009)... , DETROIT, Nov. 9 ...armanos Cancer Center has been selected the most p...higan, according to a survey by the National Resea...m.com/cgi-bin/prnh/20071106/KARMANOSLOGO ) ,, ...uestionnaire between September 2008 and August 200...
(Date:11/9/2009)... Study didn,t answer question of why this is so, ...News) -- After a lumpectomy, women with very dense...n the affected breast, a new study shows. , Bre...sed risk of developing breast cancer, and experts ... associated with an increased risk of cancer recur...
Breaking Medicine News(10 mins):Health News:Fitness.com.au Poll Finds 80% Blame Parents For Our Overweight Kids 2Health News:High Impact Sports Participation May Improve Bone Mineral Density in Mature Athletes 2Health News:Health Connect Partners Hosts Hospital O.R. & Surgery Center Conference 2Health News:Karmanos Cancer Center Most Preferred Hospital for Cancer Care in Southeast Michigan, Third Consecutive Year 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 2Health News:Dense Breasts Raise Risk of Cancer Recurrence 3
...thorities have broken off talks with striking doct...inister's office for about 20 days to demand highe..."There will be no more discussions with the unions...ent had offered pay increases in 2008 but the stri...
...dy has shown that taking selenium supplements may,... The study, published in the Annals of Interna... that selenium supplements cause type 2 diabetes, ...nium is a naturally occurring trace mineral presen...
...tle life fraught with danger, for pre-mature babie...-preemies , as they weigh less than 1000 grams, th... tiny babies. Doctors who care for these low...le. Though advances in medical technology have i...
...irst time, researchers have shown that plant growt...nal light . Using time-lapse photography, ...eagues from the University of California, Davis, a...ming of that growth spurt is controlled by both th...
...ver cases in affluent Singapore have surged to the...levels, official figures showed Tuesday . ...ected last week, the second week in a row that the...nistry and the National Environment Agency said in...
...r to be published in the July issue of Cancer Biol...eports finding a significant link between genetic ...8 and the risk of colorectal cancer. A 10-yea...n in the search for the genes that make a person m...
Other Medicine News:Health News:Selenium Supplements may Increase Type 2 Diabetes Risk 2Health News:Medical Science Strides-No Guarantee For Pre-Mature Babies 2Health News:Advancement in Gene Associated With Colon Cancer 2Health News:Advancement in Gene Associated With Colon Cancer 3Health News:Advancement in Gene Associated With Colon Cancer 4
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: